Search

Bio Roundup: Big Approvals, ICER Influence, Drug-Price Pushback & More

BIO ROUNDUP: BIG APPROVALS, ICER INFLUENCE, DRUG-PRICE PUSHBACK & MORE

We'll start the roundup this week with two drug approvals that came late last Friday. Both were landmarks for the companies receiving...

Pain Drug Race Continues as Regeneron Posts Early Phase 3 Results

PAIN DRUG RACE CONTINUES AS REGENERON POSTS EARLY PHASE 3 RESULTS

A new class of pain drugs that might offer an alternative to addictive opioids-if they're safe enough to use chronically-is inching...